Inhibition of Mesothelin as a Novel Strategy for Targeting Cancer Cells

Mesothelin, a differentiation antigen present in a series of malignancies such as mesothelioma, ovarian, lung and pancreatic cancer, has been studied as a marker for diagnosis and a target for immunotherapy. We, however, were interested in evaluating the effects of direct targeting of Mesothelin on...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kun, Bodempudi, Vidya, Liu, Zhengian, Borrego-Diaz, Emma, Yamoutpoor, Farnaz, Meyer, Anna, Woo, Richard A., Pan, Weihong, Dudek, Arkadiusz Z., Olyaee, Mojtaba S., Esfandyari, Tuba, Farassati, Faris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317639/
https://www.ncbi.nlm.nih.gov/pubmed/22485139
http://dx.doi.org/10.1371/journal.pone.0033214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317639/
https://www.ncbi.nlm.nih.gov/pubmed/22485139
http://dx.doi.org/10.1371/journal.pone.0033214

Ejemplares similares